Skip to main content
Email Print Share

21st Century Scientist: Seeing Tiny Cancer "Markers" Sooner -- Chemistry Now


21st Century Scientist: Seeing Tiny Cancer "Markers" Sooner

In this 21st Century Chemist profile, Purdue University analytical chemist Mary Wirth works with "nanomaterials" to improve the clarity and accuracy of tests for tiny "biomarker" proteins that indicate disease -- specifically, levels of PSAs, or Prostate Specific Antigens, that signal prostate cancer.

Credit: NBC Learn and the National Science Foundation

General Restrictions:
Images and other media in the National Science Foundation Multimedia Gallery are available for use in print and electronic material by NSF employees, members of the media, university staff, teachers and the general public. All media in the gallery are intended for personal, educational and nonprofit/non-commercial use only.

Videos credited to the National Science Foundation, an agency of the U.S. Government, may be distributed freely. However, some materials within the videos may be copyrighted. If you would like to use portions of NSF-produced programs in another product, please contact the Video Team in the Office of Legislative and Public Affairs at the National Science Foundation. Additional information about general usage can be found in Conditions.